BVT Bonus Zert AMD 31.12.2024/ DE000VM7B4X1 /
2024-09-06 8:03:48 PM | Chg.-5.190 | Bid9:59:16 PM | Ask9:59:16 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
140.240EUR | -3.57% | - Bid Size: - |
- Ask Size: - |
Advanced Micro Devic... | - USD | 2024-12-31 | Call |
GlobeNewswire
09-01
Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer
GlobeNewswire
08-27
Clearside Biomedical Announces Completion of Final Participant Visit in ODYSSEY Phase 2b Trial of CL...
GlobeNewswire
08-27
EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
GlobeNewswire
08-26
Aura Biosciences Announces the Presentation of Phase 2 End of Study Data Evaluating Suprachoroidal A...
GlobeNewswire
08-23
AiViva Biopharma Completes Enrollment in a Phase 1 Clinical Trial of AIV007 for Age-Related Macular ...
GlobeNewswire
08-21
AMD 2023-24 Corporate Responsibility Report: Advancing Sustainability, Collaboration and Inclusion
GlobeNewswire
08-20
FUJIFILM Diosynth Biotechnologies Celebrates Opening of Billingham, UK Microbial Manufacturing Facil...
GlobeNewswire
08-20
Gamescom 2024 - HP Elevates the Gaming World through Customizable Solutions for a Personalized Playe...
GlobeNewswire
08-19
AMD to Significantly Expand Data Center AI Systems Capabilities with Acquisition of Hyperscale Solut...
GlobeNewswire
08-16
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
08-14
Outlook Therapeutics® Reports Financial Results for Third Quarter Fiscal Year 2024 and Provides Corp...
GlobeNewswire
08-12
Adverum Biotechnologies Reports Second Quarter 2024 Financial Results and Provides Program and Corpo...
GlobeNewswire
08-12
Clearside Biomedical Announces Second Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
08-12
Outlook Therapeutics® to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference